Lead Product(s) : Sugammadex Sodium
Therapeutic Area : Neurology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Acquired Approval for Manufacturing and Marketing Generic Drugs
Details : Sugammadex is a generic version of bridion which is indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery.
Product Name : Sugammadex Intravenous Solution
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 15, 2024
Lead Product(s) : Sugammadex Sodium
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sugammadex Sodium
Therapeutic Area : Musculoskeletal
Study Phase : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Gland Pharma Receives Tentative Approval for Sugammadex Injection
Details : Sugammadex injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL is generic bioequivalent and therapeutically equivalent to Bridion injection of Merck used to reverse the effects of the muscle relaxants rocuronium bromide and vecuronium bromide given to pat...
Product Name : Undisclosed
Product Type : Small molecule
Upfront Cash : Not Applicable
October 08, 2021
Lead Product(s) : Sugammadex Sodium
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Reset All
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
